Androski Lindsay sold ABUS
October 1, 2026 · Form 4 insider transaction
Androski Lindsay sold 24,655 shares of Arbutus Biopharma Corporation at $5.00 per share, a transaction worth $123.3K. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Disposed (sell-side)
Shares
24,655
Price
$5.00
Total value
$123.3K
InsiderAndroski Lindsay
Role—
SecurityCommon Shares
Transaction codeD: Disposition to the issuer
Transaction dateOctober 1, 2026
Filing dateOctober 7, 2026
Shares owned after47,682
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents common shares tendered to the Issuer pursuant to the Issuer's tender offer. The Issuer took up and accepted the common shares for payment on October 1, 2026.